covid-19 Coronavirus

U.S. mulls Pfizer vaccine approval: Here’s what we know about their rollout plan

Reading now: 366
globalnews.ca

vaccine experts will meet today to consider Pfizer’s vaccine, and again on Dec. 17 for Moderna’s. The Vaccines and Related Biological Products Advisory Committee, made up of independent vaccine experts, infectious disease specialists, industry representatives and a consumer representative, will pick apart Pfizer’s data for any red flags.

They will debate whether the shot is safe and effective enough to be cleared for emergency use.Then, they will vote. That vote could come as early as Thursday afternoon.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA